内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

2021 JSTO/JDS/JASSO联合共识声明：代谢手术治疗2型糖尿病

2021-11-08 日本糖尿病学会 Diabetol Int

糖尿病代谢手术代谢外科

2021年11月，日本肥胖治疗学会(JSTO)联合日本糖尿病学会(JDS)、日本肥胖研究学会(JASSO)共同发布了代谢手术治疗2型糖尿病共识声明。

中文标题：

2021 JSTO/JDS/JASSO联合共识声明：代谢手术治疗2型糖尿病

英文标题：

Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity

发布机构：

日本糖尿病学会

发布日期：

2021-11-08

简要介绍：

2021年11月，日本肥胖治疗学会(JSTO)联合日本糖尿病学会(JDS)、日本肥胖研究学会(JASSO)共同发布了代谢手术治疗2型糖尿病共识声明。减重手术已经被证实对于2型糖尿病患者具有多种代谢获益，也称为代谢手术。本文就肥胖和代谢手术治疗2型糖尿病达成共识。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 JSTO_JDS_JASSO联合共识声明：代谢手术治疗2型糖尿病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e8e751c00226a56c, title=2021 JSTO/JDS/JASSO联合共识声明：代谢手术治疗2型糖尿病 , enTitle=Metabolic surgery in treatment of obese Japanese patients with type 2 diabetes: a joint consensus statement from the Japanese Society for Treatment of Obesity, the Japan Diabetes Society, and the Japan Society for the Study of Obesity, guiderFrom=Diabetol Int, authorId=0, author=, summary=2021年11月，日本肥胖治疗学会(JSTO)联合日本糖尿病学会(JDS)、日本肥胖研究学会(JASSO)共同发布了代谢手术治疗2型糖尿病共识声明。, cover=https://img.medsci.cn/20211116/1637053421359_5579292.jpg, journalId=0, articlesId=null, associationId=1855, associationName=日本糖尿病学会, associationIntro=, copyright=0, guiderPublishedTime=Mon Nov 08 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年11月，日本肥胖治疗学会(JSTO)联合日本糖尿病学会(JDS)、日本肥胖研究学会(JASSO)共同发布了代谢手术治疗2型糖尿病共识声明。减重手术已经被证实对于2型糖尿病患者具有多种代谢获益，也称为代谢手术。本文就肥胖和代谢手术治疗2型糖尿病达成共识。</span></p>, tagList=[TagDto(tagId=43661, tagName=糖尿病代谢手术), TagDto(tagId=117839, tagName=代谢外科)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=43661, guiderKeyword=糖尿病代谢手术, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1757, appHits=58, showAppHits=0, pcHits=271, showPcHits=1699, likes=1, shares=7, comments=4, approvalStatus=1, publishedTime=Wed Nov 17 00:08:30 CST 2021, publishedTimeString=2021-11-08, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Tue Nov 16 22:05:37 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Thu Jan 04 14:51:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 JSTO_JDS_JASSO联合共识声明：代谢手术治疗2型糖尿病.pdf)])
2021 JSTO_JDS_JASSO联合共识声明：代谢手术治疗2型糖尿病.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200655, encodeId=a2e91200655dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073807, encodeId=e1f210e38073e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f04a5642946, createdName=ms6000000710651942, createdTime=Thu Nov 25 11:29:39 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070952, encodeId=fe5510e09525f, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83441602224, createdName=331615308, createdTime=Wed Nov 17 00:48:34 CST 2021, time=2021-11-17, status=1, ipAttribution=)]
    2022-03-08 Svana

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200655, encodeId=a2e91200655dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073807, encodeId=e1f210e38073e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f04a5642946, createdName=ms6000000710651942, createdTime=Thu Nov 25 11:29:39 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070952, encodeId=fe5510e09525f, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83441602224, createdName=331615308, createdTime=Wed Nov 17 00:48:34 CST 2021, time=2021-11-17, status=1, ipAttribution=)]
    2021-11-25 ms6000000710651942

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200655, encodeId=a2e91200655dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/7aeaf4b9c36f43f2a16c9d70777d9ab8/57ab422ee66c4a89a732809040711f06.jpg, createdBy=bdfe5483549, createdName=Svana, createdTime=Tue Mar 08 20:16:53 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073807, encodeId=e1f210e38073e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f04a5642946, createdName=ms6000000710651942, createdTime=Thu Nov 25 11:29:39 CST 2021, time=2021-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070952, encodeId=fe5510e09525f, content=已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=83441602224, createdName=331615308, createdTime=Wed Nov 17 00:48:34 CST 2021, time=2021-11-17, status=1, ipAttribution=)]
    2021-11-17 331615308

    已学习

    0